The purpose of the study is to determine whether multiple doses of secretin are safe and
effective in the treatment of children with autism.
Minimum age: 32 Months.
Maximum age: 59 Months.
Gender(s): Both.
Southwest Autism Research Center, Phoenix, Arizona, United States
UCLA Pediatric Neurology, Los Angeles, California 90095-1752, United States
Children's Hospital and Research Center at Oakland, Oakland, California 94609, United States
1st Allergy & Clinical Research Center, Centennial, Colorado 80112, United States
Alachua Family Psychiatry, Gainesville, Florida 32607, United States
Miami Children's Hospital, Miami, Florida, United States
Riley Children's Hospital, Indianapolis, Indiana 46202-5200, United States
The Clinical Trials Center:A Division of Children's Hospital, Metairie, Louisiana 70006, United States
Hardy Healthcare Associates, Hingham, Massachusetts, United States
Children's Hospital of Michigan, Detroit, Michigan 48201, United States
University of Medicine and Dentistry of New Jersey, Newark, New Jersey 07107, United States
Schneider Children's Hospital, New Hyde Park, New York, United States
The Ohio State University, Columbus, Ohio 43210, United States
Children's Biomedical Center of Utah, Sandy, Utah 84093, United States
Puget Sound Neurology, Edmonds, Washington 98026, United States